Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort

Gencer, Baris; Pagano, Sabrina; Vuilleumier, Nicolas; Satta Poschung, Nathalie; Delhumeau-Cartier, Cécile; Meier, Christoph; Bavamian Suter, Sabine; Montecucco, Fabrizio; Mach, François; Calmy, Alexandra

doi:10.1016/j.atherosclerosis.2019.02.015

Scientific article

English

Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort

ContributorsGencer, Baris; Pagano, Sabrina

; Vuilleumier, Nicolas; Satta Poschung, Nathalie; Delhumeau-Cartier, Cécile; Meier, Christoph; Bavamian Suter, Sabine; Montecucco, Fabrizio; Mach, François; Calmy, Alexandra

Published inAtherosclerosis, vol. 284, p. 253-259

Publication date2019

Abstract

Better characterization of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) profile is currently needed to tailor appropriate lipid-lowering strategies in HIV patients.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Funding

Swiss National Science Foundation - 148522
Swiss National Science Foundation - Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management
Swiss National Science Foundation - Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management [140336]

Citation (ISO format)

GENCER, Baris et al. Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort. In: Atherosclerosis, 2019, vol. 284, p. 253–259. doi: 10.1016/j.atherosclerosis.2019.02.015

Article (Published version)

Identifiers

PID : unige:121602
DOI : 10.1016/j.atherosclerosis.2019.02.015
PMID : 30827714

Journal ISSN0021-9150

396views

1downloads

Creation14/08/2019 15:01:00

First validation14/08/2019 15:01:00

Update time24/01/2025 13:54:35

Status update24/01/2025 13:54:35

Last indexation24/01/2025 13:58:16

Archive ouverte UNIGE

Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort

Better characterization of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) profile is currently needed to tailor appropriate lipid-lowering strategies in HIV patients.

Technical informations